James Graham Brown Cancer Center [clinicaltrials_resource:bb9d1ffcedb719eeb4e5d1b7c2aa4c18]
Antonio Pellicer, MDPhD [clinicaltrials_resource:04d4442faff5f7e35e194ccdd801cc11]Anthony E. Dragun, MD [clinicaltrials_resource:0507fd22e4bd7d249d3c0b396d563828]Goetz H Kloecker, MD [clinicaltrials_resource:073b538e1962b946c592343c79539aa7]Rebecca A. Redman, MD [clinicaltrials_resource:0c36a6fdc529e8a9ba697e33a15d4419]Xiao-An Fu, PhD [clinicaltrials_resource:0c74997b5663c2bc56c4ed82f2f6f8ab]Neal E Dunlap, MD [clinicaltrials_resource:0da9b777a8fc106c6ad011a09f9d3969]Neal E Dunlap, MD [clinicaltrials_resource:0dd6c33c17c325959268cf969360098e]Shiao Y Woo, MD [clinicaltrials_resource:0f36a8cae4d9aa1b03522d7ef716928a]Eric Burton, MD [clinicaltrials_resource:10ca0fdab91014341616eaeffda8b68c]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Goetz H Kloecker, MD [clinicaltrials_resource:168d1a5a33b504645a49fc9c3acff5b4]Jason A Chesney, MD, PhD [clinicaltrials_resource:1695dbcf96f621501dabddea3d249dd7]Rebecca A. Redman, MD [clinicaltrials_resource:18d708414e2794d36c4864898d830b0c]Ramesh Gupta, PhD [clinicaltrials_resource:1b38a73b811ba930f190847c54a0eb3f]Shiao Y Woo, MD [clinicaltrials_resource:1c1486321f3b3431838982f3721da59f]Roger Herzig, M.D. [clinicaltrials_resource:1fca811451990cbfbda6e17f4af2d78f]Neal E Dunlap, MD [clinicaltrials_resource:20071d68a28cd348ae41b2bc83d18a75]Rebecca A. Redman, MD [clinicaltrials_resource:309ac798345d19dab8f08e004b41d139]Eric Burton, MD [clinicaltrials_resource:360995726481d2d2d0325e7173312dff]Rebecca A. Redman, MD [clinicaltrials_resource:3edf1ec0db9e39ff682f423741a5e60b]Jason A Chesney, MD, PhD [clinicaltrials_resource:42c60b5bdc26bf660438c2c752208c10]Eric Burton, MD [clinicaltrials_resource:4400e8229bad544f851292a4a90f2285]Shiao Y Woo, MD [clinicaltrials_resource:47f2505232127006e3fc6b6c9ef49fa9]Goetz H Kloecker, MD [clinicaltrials_resource:4ab0222f16b1c7141fd574594633fd2e]Anthony E. Dragun, MD [clinicaltrials_resource:4c8951f3ff2d8cffa86e5f929766d3ea]Anthony E. Dragun, MD [clinicaltrials_resource:4fd712056d3bf79276edce14a3b71b23]Donald M Miller, MD, Ph.D [clinicaltrials_resource:568113dc69091c4dbc6cf3b5963f4e16]Shiao Y Woo, MD [clinicaltrials_resource:58f00d51ef7a545659dfcc2114256648]Jason A Chesney, MD, PhD [clinicaltrials_resource:59b38bbcbcdc1a148353a78230690fb5]Goetz H Kloecker, MD [clinicaltrials_resource:5d3983b68d4e5264eac003f954386031]Donald M Miller, MD, Ph.D [clinicaltrials_resource:686cae4aadb12c21973185c866846358]Rebecca A. Redman, MD [clinicaltrials_resource:84734538aaf650463b5da56d85d583ae]Neal E Dunlap, MD [clinicaltrials_resource:84de8968e17fa137a801e6ab407b223c]C. William Helm, MD [clinicaltrials_resource:8bd50501a0af9d29f866501ba374a10e]Neal E Dunlap, MD [clinicaltrials_resource:8db950e7ac23e592038517ae66ed5b62]Donald M Miller, MD, Ph.D [clinicaltrials_resource:9a8525e2594c7bb3f5b2068266840e18]Donald M Miller, MD, PhD [clinicaltrials_resource:a606306f33546a0a4f3304e028347850]Xiao-An Fu, PhD [clinicaltrials_resource:a83784428f3aa47235f30525f174d3e3]Neal E Dunlap, MD [clinicaltrials_resource:aabe8d68779c30768b1e44330debad94]Jason A Chesney, MD, PhD [clinicaltrials_resource:b2ea31557d9de1acfa736a082a7d4a70]
affiliation [clinicaltrials_vocabulary:affiliation]
clinicaltrials:NCT00263731Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis [clinicaltrials:NCT00264082]clinicaltrials:NCT00265200Human Papilloma Virus DNA Self-Test [clinicaltrials:NCT00266266]clinicaltrials:NCT00266279Ovarian Screening Study [clinicaltrials:NCT00267072]Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer [clinicaltrials:NCT00268151]clinicaltrials:NCT00281021clinicaltrials:NCT00290407Prognostic Markers of Gynecologic Cancers [clinicaltrials:NCT00290459]clinicaltrials:NCT00299689clinicaltrials:NCT00474669clinicaltrials:NCT00481624clinicaltrials:NCT00553618clinicaltrials:NCT00673439The Effect of Berries on Lung Cancer Tumors [clinicaltrials:NCT00681512]The Effect of Beta-glucan in Non-Small Cell Lung Cancer [clinicaltrials:NCT00682032]Port Will be Flushed Every 3 Months Instead of Every 4-6 Wks, as Recommended by Port Manufacturer. [clinicaltrials:NCT01047644]Advanced Cervical Cancer Trial in India [clinicaltrials:NCT01276730]clinicaltrials:NCT01278212Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue [clinicaltrials:NCT01294072]A Feasibility Study Using Four-Dimensional CT Imaging for Primary Lung Cancer [clinicaltrials:NCT01500876]clinicaltrials:NCT01527292clinicaltrials:NCT01638676clinicaltrials:NCT01668849clinicaltrials:NCT01772719clinicaltrials:NCT01839552Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers [clinicaltrials:NCT01871454]clinicaltrials:NCT01874860A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70 [clinicaltrials:NCT01985087]Ipilimumab Administered to Stage IIIC and Stage IV Melanoma Patients After Regulatory T Cell Depletion With Denileukin Diftitox [clinicaltrials:NCT02009384]A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients [clinicaltrials:NCT02009397]A Micro/Nano Device for Exhaled Breath Analysis [clinicaltrials:NCT02123030]clinicaltrials:NCT02128100clinicaltrials:NCT02143050Pre and Post Treatment Metabolomic Analysis of Leukemia: A Translational Clinical Trial of the Brown Cancer Center [clinicaltrials:NCT02193100]
collaborator [clinicaltrials_vocabulary:collaborator]
clinicaltrials:NCT00263731Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis [clinicaltrials:NCT00264082]clinicaltrials:NCT00265200Human Papilloma Virus DNA Self-Test [clinicaltrials:NCT00266266]clinicaltrials:NCT00266279Ovarian Screening Study [clinicaltrials:NCT00267072]Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer [clinicaltrials:NCT00268151]clinicaltrials:NCT00281021clinicaltrials:NCT00290407Prognostic Markers of Gynecologic Cancers [clinicaltrials:NCT00290459]clinicaltrials:NCT00299689Racial Disparity in Endometrial Cancer [clinicaltrials:NCT00375804]clinicaltrials:NCT00456989clinicaltrials:NCT00474669clinicaltrials:NCT00481624clinicaltrials:NCT00553618clinicaltrials:NCT00673439The Effect of Berries on Lung Cancer Tumors [clinicaltrials:NCT00681512]The Effect of Beta-glucan in Non-Small Cell Lung Cancer [clinicaltrials:NCT00682032]Port Will be Flushed Every 3 Months Instead of Every 4-6 Wks, as Recommended by Port Manufacturer. [clinicaltrials:NCT01047644]Advanced Cervical Cancer Trial in India [clinicaltrials:NCT01276730]clinicaltrials:NCT01278212Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue [clinicaltrials:NCT01294072]clinicaltrials:NCT01300299Phase II Study of Simvastatin for Relapsed/Refractory Myeloma [clinicaltrials:NCT01332617]clinicaltrials:NCT01426620A Feasibility Study Using Four-Dimensional CT Imaging for Primary Lung Cancer [clinicaltrials:NCT01500876]clinicaltrials:NCT01527292clinicaltrials:NCT01638676clinicaltrials:NCT01668849Estimating the Adherence Rate of a Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors [clinicaltrials:NCT01694225]clinicaltrials:NCT01772719clinicaltrials:NCT01839552Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers [clinicaltrials:NCT01871454]clinicaltrials:NCT01874860A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70 [clinicaltrials:NCT01985087]Ipilimumab Administered to Stage IIIC and Stage IV Melanoma Patients After Regulatory T Cell Depletion With Denileukin Diftitox [clinicaltrials:NCT02009384]A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients [clinicaltrials:NCT02009397]A Micro/Nano Device for Exhaled Breath Analysis [clinicaltrials:NCT02123030]clinicaltrials:NCT02128100
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
clinicaltrials:NCT00263731Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis [clinicaltrials:NCT00264082]clinicaltrials:NCT00265200Human Papilloma Virus DNA Self-Test [clinicaltrials:NCT00266266]clinicaltrials:NCT00266279Ovarian Screening Study [clinicaltrials:NCT00267072]Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer [clinicaltrials:NCT00268151]clinicaltrials:NCT00281021clinicaltrials:NCT00290407Prognostic Markers of Gynecologic Cancers [clinicaltrials:NCT00290459]clinicaltrials:NCT00299689Racial Disparity in Endometrial Cancer [clinicaltrials:NCT00375804]clinicaltrials:NCT00456989clinicaltrials:NCT00474669clinicaltrials:NCT00481624clinicaltrials:NCT00553618clinicaltrials:NCT00673439The Effect of Berries on Lung Cancer Tumors [clinicaltrials:NCT00681512]The Effect of Beta-glucan in Non-Small Cell Lung Cancer [clinicaltrials:NCT00682032]Port Will be Flushed Every 3 Months Instead of Every 4-6 Wks, as Recommended by Port Manufacturer. [clinicaltrials:NCT01047644]Advanced Cervical Cancer Trial in India [clinicaltrials:NCT01276730]clinicaltrials:NCT01278212Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue [clinicaltrials:NCT01294072]clinicaltrials:NCT01300299Phase II Study of Simvastatin for Relapsed/Refractory Myeloma [clinicaltrials:NCT01332617]clinicaltrials:NCT01426620A Feasibility Study Using Four-Dimensional CT Imaging for Primary Lung Cancer [clinicaltrials:NCT01500876]clinicaltrials:NCT01527292clinicaltrials:NCT01638676clinicaltrials:NCT01668849Estimating the Adherence Rate of a Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors [clinicaltrials:NCT01694225]clinicaltrials:NCT01772719clinicaltrials:NCT01839552Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers [clinicaltrials:NCT01871454]clinicaltrials:NCT01874860A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70 [clinicaltrials:NCT01985087]Ipilimumab Administered to Stage IIIC and Stage IV Melanoma Patients After Regulatory T Cell Depletion With Denileukin Diftitox [clinicaltrials:NCT02009384]A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients [clinicaltrials:NCT02009397]A Micro/Nano Device for Exhaled Breath Analysis [clinicaltrials:NCT02123030]clinicaltrials:NCT02128100
source [clinicaltrials_vocabulary:source]
James Graham Brown Cancer Center [clinicaltrials_resource:bb9d1ffcedb719eeb4e5d1b7c2aa4c18]
Bio2RDF identifier
bb9d1ffcedb719eeb4e5d1b7c2aa4c18
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:bb9d1ffcedb719eeb4e5d1b7c2aa4c18
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:bb9d1ffcedb719eeb4e5d1b7c2aa4c18
title
James Graham Brown Cancer Center
@en
type
label
James Graham Brown Cancer Cent ...... d1ffcedb719eeb4e5d1b7c2aa4c18]
@en